These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19233915)

  • 1. Counterpoint: pharmacogenetic-based initial dosing of warfarin: not ready for prime time.
    Eby CS
    Clin Chem; 2009 Apr; 55(4):712-4. PubMed ID: 19233915
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: meta-analysis of randomized controlled trials.
    Li X; Yang J; Wang X; Xu Q; Zhang Y; Yin T
    Thromb Res; 2015 Apr; 135(4):621-9. PubMed ID: 25628141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefits of pharmacogenetic algorithm-based warfarin dosing: Meta-analysis of randomized controlled trials: Comment.
    Belley-Côté EP; Whitlock RP; French B; Evaniew N; Kimmel SE
    Thromb Res; 2015 Jul; 136(1):180-1. PubMed ID: 26004747
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetics-based warfarin dosing algorithm decreases time to stable anticoagulation and the risk of major hemorrhage: an updated meta-analysis of randomized controlled trials.
    Wang ZQ; Zhang R; Zhang PP; Liu XH; Sun J; Wang J; Feng XF; Lu QF; Li YG
    J Cardiovasc Pharmacol; 2015 Apr; 65(4):364-70. PubMed ID: 25551322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.
    Gulseth MP; Grice GR; Dager WE
    Am J Health Syst Pharm; 2009 Jan; 66(2):123-33. PubMed ID: 19139476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic-guided dosing for warfarin: too little too late?
    Wu AH
    Per Med; 2018 Mar; 15(2):71-73. PubMed ID: 29714120
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.
    Shi C; Yan W; Wang G; Wang F; Li Q; Lin N
    PLoS One; 2015; 10(12):e0144511. PubMed ID: 26672604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
    Schwartz JB; Kane L; Moore K; Wu AH
    J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.
    Xu H; Xie X; Wang B; Chen Y; Meng T; Ma S; Wang F
    Int J Cardiol; 2014 Dec; 177(2):654-7. PubMed ID: 25449474
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of warfarin dose: why, when and how?
    Eriksson N; Wadelius M
    Pharmacogenomics; 2012 Mar; 13(4):429-40. PubMed ID: 22379999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-guided warfarin therapy: current status.
    Tavares LC; Marcatto LR; Santos PCJL
    Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.
    Gage BF; Eby C; Milligan PE; Banet GA; Duncan JR; McLeod HL
    Thromb Haemost; 2004 Jan; 91(1):87-94. PubMed ID: 14691573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
    Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
    Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation endpoints with clinical implementation of warfarin pharmacogenetic dosing in a real-world setting: A proposal for a new pharmacogenetic dosing approach.
    Arwood MJ; Deng J; Drozda K; Pugach O; Nutescu EA; Schmidt S; Duarte JD; Cavallari LH
    Clin Pharmacol Ther; 2017 May; 101(5):675-683. PubMed ID: 28032893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort.
    Shin J; Kayser SR
    Pharmacotherapy; 2011 Sep; 31(9):863-70. PubMed ID: 21923587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Value of Evidence in the Decision-Making Process for Reimbursement of Pharmacogenetic Dosing of Warfarin.
    Janzic A; Locatelli I; Kos M
    Am J Cardiovasc Drugs; 2017 Oct; 17(5):399-408. PubMed ID: 28528365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-Guided Dosing of Coumarin Anticoagulants: A Meta-analysis of Randomized Controlled Trials.
    Tang T; Liu J; Zuo K; Cheng J; Chen L; Lu C; Han S; Xu J; Jia Z; Ye M; Pei E; Zhang X; Li M
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):387-94. PubMed ID: 25575537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing.
    Roper N; Storer B; Bona R; Fang M
    J Mol Diagn; 2010 May; 12(3):283-91. PubMed ID: 20228265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Performance of the Warfarin Pharmacogenetics Algorithms in Patients with Surgery of Heart Valve Replacement and Heart Valvuloplasty.
    Xu H; Su S; Tang W; Wei M; Wang T; Wang D; Ge W
    Thromb Res; 2015 Sep; 136(3):552-9. PubMed ID: 26188922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of coumarinic oral anticoagulants.
    Manolopoulos VG; Ragia G; Tavridou A
    Pharmacogenomics; 2010 Apr; 11(4):493-6. PubMed ID: 20350128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.